期刊文献+

硫辛酸联合甲钴胺治疗糖尿病神经源性膀胱的疗效观察 被引量:4

The study on the treatment of diabetic neurogenic bladder with lipoic acid combined with mecobalamin
下载PDF
导出
摘要 目的观察硫辛酸与甲钴胺联合应用治疗糖尿病神经源性膀胱的疗效。方法将56例糖尿病神经源性膀胱患者随机分为两组,治疗组联用硫辛酸与甲钴胺治疗,对照组单用甲钴胺治疗。结果治疗组有效率85.7%,对照组有效率60.7%,两组间比较,差异有统计学意义(P<0.05)。膀胱残余尿量治疗前后比较,两组患者均有明显改善(P<0.01),而治疗组优于对照组(P<0.05)。结论硫辛酸与甲钴胺联用治疗糖尿病神经源性膀胱优于单用甲钴胺治疗。 Objective To observe the therapeutic effect of lipoic acid combined with mecobalamin on diabetic neurogenic bladder.Methods 56 patients with diabetic neurogenic bladder were divided into two groups at random,the treatment group was treated with lipoic acid combined with mecobalamin and the control group was treated with mecobalamin.Results The effective power of the treatment group was 85.7%and the control group was 60.7%,they had statistical diference(P0.05).Compared with prior treatment,the bladder residue urine of two group were both decreased significantly(P0.01)and the treated group was superior to the control group(P0.05).Conclusion The lipoic acid combined with mecobalamin in treating diabetic neurogenic bladder has a better clinical therapeutic effect than mecobalamin only.
出处 《中国实用医药》 2010年第36期46-47,共2页 China Practical Medicine
关键词 硫辛酸 甲钴胺 糖尿病 神经源性膀胱 Lipoic acid Mecobalamin Diabetes Neurogenic bladder
  • 相关文献

参考文献1

二级参考文献35

  • 1Brown JS, Wessells H, Chancellor MB, Howards SS, Stamm WE, Stapleton AE, et al. Urologic complications of diabetes. Diabetes Care 2005; 28: 177-85.
  • 2Yoshimura N, Chancellor MB, Andersson KE, Christ GJ. Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int 2005; 95: 733-8.
  • 3Bradley WE. Diagnosis of urinary bladder dysfunction in diabetes mellitus. Ann Intern Med 1980; 92: 323-6.
  • 4Ueda T, Yoshimura N, Yoshida O. Diabetic cystopathy: relationship to autonomic neuropathy detected by sympathetic skin response. J Urol 1997; 157: 580-4.
  • 5Sasaki K, Chancellor MB, Phelan MW, Yokoyama T, Fraser MO, Seki S. Diabetic cystopathy correlates with long-term decrease in nerve growth factor (NGF) levels in the bladder and lumbosacral dorsal root ganglia. J Urol 2002; 168:1259-64.
  • 6Sen CK, Packer L. Thiol homeostasis and supplements in physical exercise. Am J Clin Nutr 2000; 72: S653-69.
  • 7Packer L, Kraemer K, Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 2001; 17: 888-95.
  • 8Bhatti F, Mankhey RW, Asico L, Quinn MT, Welch WJ, Maric C. Mechanisms of antioxidant and pro-oxidant effects of alphalipoic acid in the diabetic and nondiabetic kidney. Kideny Int 2005; 67:1371-80.
  • 9Shotton HR, Broadbent S, Lincoln J. Prevention and partial reversal of diabetes-induced changes in enteric nerves of the rat ileum by combined treatment with alpha-lipoid acid and evening primrose oil. Auton Neurosci 2004; 111: 57-65.
  • 10Ziegler D, Ametov A, Barinov A, Dyck P J, Gurieva I, Low PA, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2006; 29: 2365-70.

共引文献11

同被引文献37

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部